What They’re Watching: Rep. Brad Daw

Representative Brad Daw is the Chair of the House Health and Human Services Committee and is a member of the Health Reform Taskforce. He joins us in this edition of “What They’re Watching” to discuss transparency in pricing.

 

Get the latest state-specific policy intelligence for the health care sector delivered to your inbox.

 

“You know, one of the things I’ve been looking at recently has to do with health care transparency of pricing — both on the services side and on the pharmaceutical side. Turns out they’re two wildly different scenarios and we need to look at both of them to try to connect the consumer with what the cost of health care is.

I mean, it’s interesting. You go into a lot of places right now and ask them how much a particular service costs or something like that, and they will give you a blank stare. “Well it depends on what the insurance provider pays,” “well it depends on what the billing rate is,” and on and on and on. And instead of having a flat rate or a reasonable range or something like that, they don’t know. And we need to get the person engaged back in that process of how much things cost, and get the consumer more attached to their insurance policy. Right now, you’re completely isolated from it. For example, most people get their policies through their employer. They have no idea what the premiums are; they don’t really have any great incentive to save any money because they don’t see it one way or the other. And so, if we can get the consumer a little bit more connected with paying that money out, I think we’ll see some really positive differences.”